Annals of Oncology

News:

Freedom under attack: Terrorists hit the USA
Ann Oncol 12: 1335.
[PDF] [Request Permissions]

Stopping the indiscriminate killers
Ann Oncol 12: 1335.
[PDF] [Request Permissions]

US banned all human cloning after rejecting a plan to allow the procedure for research only, but...
Ann Oncol 12: 1335.
[PDF] [Request Permissions]

Are smokers actually a bonus for the Social Security systems?
Ann Oncol 12: 1335-1336.
[PDF] [Request Permissions]

What is a correct difference in prices?
Ann Oncol 12: 1336.
[PDF] [Request Permissions]

Will Novartis merge with Roche?
Ann Oncol 12: 1336.
[PDF] [Request Permissions]

Mediterranean diet? Maybe, but go to Oklnawa...
Ann Oncol 12: 1336-1337.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 12: 1337-1338.
[PDF] [Request Permissions]

US patients' bill of rights
Ann Oncol 12: 1337.
[PDF] [Request Permissions]

Editorial:

P. A. Bunn, Jr.

Editorial comments on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study’
Ann Oncol 12: 1339-1340.
[PDF] [Request Permissions]

Reviews:

S. Darby, D. Hill, and R. Doll

Radon: A likely carcinogen at all exposures
Ann Oncol 12: 1341-1351.
[Abstract] [PDF] [Request Permissions]

J.T. Tamsma, H. J. Keizer, and A. E. Meinders

Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited
Ann Oncol 12: 1353-1357.
[Abstract] [PDF] [Request Permissions]

Original articles:

V. C. G. Tjan-Heijnen, P. E. Postmus, A. Ardizzoni, Ch. Manegold, J. Burghouts, J. van Meerbeeck, S. Gans, M. Mollers, E. Buchholz, B. Biesma, C. Legrand, C. Debruyne, and G. Giaccone

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study
Ann Oncol 12: 1359-1368.
[Abstract] [PDF] [Request Permissions]

J. Feliu, G. Martín, J. Lizón, J. I. Chacón, J. Dorta, J. de Castro, A. Rodríguez, B. Sánchez Heras, J. C. Torrego, E. Espinosa, and M. González Barón

Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin—gemcitabine—vinorelbine. A phase II study
Ann Oncol 12: 1369-1374.
[Abstract] [PDF] [Request Permissions]

J. Jassem, R. Ramlau, H. Karnicka-Mlodkowska, K. Krawczyk, M. Krzakowski, P. Zatloukal, E. Lemarié, W. Hartmann, L. Novakova, M. O'Brien, and A. Depierre

A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients
Ann Oncol 12: 1375-1381.
[Abstract] [PDF] [Request Permissions]

D. Granberg, B. Eriksson, E. Wilander, P. Grimfjärd, M.-L. Fjällskog, K. Öberg, and B. Skogseid

Experience in treatment of metastatic pulmonary carcinoid tumors
Ann Oncol 12: 1383-1391.
[Abstract] [PDF] [Request Permissions]

H. J. Stemmler, K. Gutschow, H. Sommer, M. Malekmohammadi, Ch. Kentenich, R. Forstpointner, S. Geuenich, J. Bischoff, W. Hiddemann, and V. Heinemann

Weekly docetaxel (Taxotere^®) in patients with metastatic breast cancer
Ann Oncol 12: 1393-1398.
[Abstract] [PDF] [Request Permissions]

S. Halford, D. Yip, C. S. Karapetis, A. H. Strickland, A. Steger, H. T. Khawaja, and P. G. Harper

A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma
Ann Oncol 12: 1399-1402.
[Abstract] [PDF] [Request Permissions]

J. O. Gallardo, B. Rubio, M. Fodor, L. Orlandi, M. Yanez, C. Gamargo, and M. Ahumada

A phase II study of gemcitabine in gallbladder carcinoma
Ann Oncol 12: 1403-1406.
[Abstract] [PDF] [Request Permissions]

H. J. Mackay, A. McInnes, J. Paul, N. Raby, F. J. Lofts, A. C. McDonald, M. Soukop, G. M. Fullarton, A. L. Harris, J. Garcia-Vargas, and T. R. J. Evans

A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
Ann Oncol 12: 1407-1410.
[Abstract] [PDF] [Request Permissions]

J.-L. Misset, Ph. Vennin, Ph. Chollet, P. Pouillart, Ph. Laplaige, J. L. Frobert, D. Castera, M. Fabro, D. Langlois, E. Cortesi, V. Lucas, E. Gamelin, A. Laadem, and J. Otero

Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients
Ann Oncol 12: 1411-1415.
[Abstract] [PDF] [Request Permissions]

D. Pectasides, G. Aravantinos, H. Kalofonos, C. Kiamouris, D. Bafaloukos, N. Xiros, C. Nicolaides, A. Visvikis, and M. A. Dimopoulos

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
Ann Oncol 12: 1417-1422.
[Abstract] [PDF] [Request Permissions]

W. Ruka, P. Rutkowski, J. Kaminska, A. Rysinska, and J. Steffen

Alterations of routine blood tests in adult patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognostic significance
Ann Oncol 12: 1423-1432.
[Abstract] [PDF] [Request Permissions]

S. P. Jagdev, O. P. Purohit, S. Heatley, C. Herling, and R. E. Coleman

Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease
Ann Oncol 12: 1433-1438.
[Abstract] [PDF] [Request Permissions]

D. Machover, B. Delmas-Marsalet, S.C. Misra, Y. Gumus, E. Goldschmidt, A. Schilf, N. Frénoy, J.-F. Emile, B. Debuire, C. Guettier, P. Farrokhi, B. Boulefdaoui, F. Norol, N. Parquet, A. Ulusakarya, and C. Jasmin

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma
Ann Oncol 12: 1439-1443.
[Abstract] [PDF] [Request Permissions]

S. A. Pileri, P. L. Zinzani, S. Ascani, G. Fraternali Orcioni, B. Gamberi, M. Piccioli, E. Sabattini, S. Poggi, P. P. Piccaluga, and B. Falini

Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases
Ann Oncol 12: 1445-1453.
[Abstract] [PDF] [Request Permissions]

J. F. Seymour, A. P. Grigg, J. Szer, and R. M. Fox

Fludarabine and mitoxantrone: Effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders
Ann Oncol 12: 1455-1460.
[Abstract] [PDF] [Request Permissions]

G. Freyer, B. Ligneau, M. Schlumberger, C. Blandy, B. Contedevolx, V. Trillet-Lenoir, G. M. Lenoir, N. Chau, and A. Dazord

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations
Ann Oncol 12: 1461-1465.
[Abstract] [PDF] [Request Permissions]

F. Levi, F. Lucchini, E. Negri, P. Boyle, and C. La Vecchia

Changed trends of cancer mortality in the elderly
Ann Oncol 12: 1467-1477.
[Abstract] [PDF] [Request Permissions]

M. Bendandi, R. Tonelli, R. Maffei, S. Botti, C. Turi, R. Sartini, S. Inoges, M. Rodriguez Calvillo, P. L. Zinzani, A. Pession, S. A. Pileri, and G. Paolucci

Identification of the B-cell tumor-specific molecular fingerprint using non-radiolabelled PCR consensus primers
Ann Oncol 12: 1479-1484.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

C. S. Karapetis, A. H. Strickland, D. Yip, J. D. van der Walt, and P. G. Harper

PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis
Ann Oncol 12: 1485-1488.
[Abstract] [PDF] [Request Permissions]

V. Grünwald, S. Le Blanc, J. H. Karstens, T. Weihkopf, M. Kuske, A. Ganser, and P. Schöffski

Metastatic malignant ameloblastoma responding to chemotherapy with paclitaxel and carboplatin
Ann Oncol 12: 1489-1491.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

T. K. Saikia, H. Menon, and S. H. Advani

Prolonged neutropenia following anti CD20 therapy in a patient with relapsed follicular non-Hodgkin's lymphoma and corrected with IVIG
Ann Oncol 12: 1493-1494.
[PDF] [Request Permissions]

A. Di Mario, L. Pagano, L. Mele, V. de Stefano, and G. Leone

Use of gemcitabine (GEM) in adanced myelodysplastic syndromes
Ann Oncol 12: 1494.
[PDF] [Request Permissions]

Book reviews:

R. Ott

Book review
Ann Oncol 12: 1495.
[PDF] [Request Permissions]

L. Biganzoli

Book review
Ann Oncol 12: 1496.
[PDF] [Request Permissions]

B. Escudier

Book review
Ann Oncol 12: 1497.
[PDF] [Request Permissions]

Corrigendum:

Corrigendum
Ann Oncol 12: 1498.
[Abstract] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.